Join
Live feed
·
PRReleasevia Quantisnow
Spero Therapeutics Inc. logo

Spero Therapeutics Announces Fourth Quarter and Full Year 2025 Operating Results and Provides a Business Update

ByQuantisnow·Wall Street's wire, on your screen.
SPRO· Spero Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SPRO (Spero Therapeutics Inc.) and more on Quantisnow.